Armata Pharmaceuticals, Inc. (ARMP) Form 10-Q Quarterly Reports
Armata Pharmaceuticals, Inc. (ARMP) is a publicly traded company on the NYSE, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ARMP
CIK: 921114
Exchange: NYSE
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: WA
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerBrian Valenzuela
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-23 | 2026-09-23 | FORM 8-K | 0001104659-26-109809 | View SEC Doc Filr Page |
| 8-K | 2026-09-14 | 2026-09-14 | FORM 8-K | 0001104659-26-107253 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | 10-Q | 0001104659-26-094907 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-12 | 8-K | 0001104659-26-094896 | View SEC Doc Filr Page |
| 8-K | 2026-07-20 | 2026-07-20 | FORM 8-K | 0001104659-26-084861 | View SEC Doc Filr Page |
| 8-K | 2026-07-20 | 2026-07-17 | FORM 8-K | 0001104659-26-084860 | View SEC Doc Filr Page |
| 4 | 2026-07-14 | 2026-07-10 | OWNERSHIP DOCUMENT | 0001104659-26-083516 | View SEC Doc Filr Page |
| 8-K | 2026-07-13 | 2026-07-13 | FORM 8-K | 0001104659-26-082850 | View SEC Doc Filr Page |
| S-8 | 2026-07-13 | — | FORM S-8 | 0001104659-26-082751 | View SEC Doc Filr Page |
| 8-K/A | 2026-06-24 | 2026-04-24 | 8-K/A | 0001104659-26-077313 | View SEC Doc Filr Page |
| 8-K | 2026-06-23 | 2026-06-23 | FORM 8-K | 0001104659-26-076627 | View SEC Doc Filr Page |
| 8-K | 2026-06-16 | 2026-06-11 | FORM 8-K | 0001104659-26-074618 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-05-13 | — | SCHEDULE 13D/A Filing | 0001104659-26-060384 | View SEC Doc Filr Page |
| 10-Q | 2026-05-13 | 2026-03-31 | 10-Q | 0001104659-26-060333 | View SEC Doc Filr Page |
| 8-K | 2026-05-13 | 2026-05-12 | 8-K | 0001104659-26-060299 | View SEC Doc Filr Page |
| 8-K | 2026-05-07 | 2026-05-07 | FORM 8-K | 0001104659-26-056658 | View SEC Doc Filr Page |
| 4 | 2026-04-28 | 2026-04-24 | OWNERSHIP DOCUMENT | 0001104659-26-050391 | View SEC Doc Filr Page |
| 3 | 2026-04-28 | 2026-04-24 | OWNERSHIP DOCUMENT | 0001104659-26-050386 | View SEC Doc Filr Page |
| ARS | 2026-04-27 | 2025-12-31 | ARS | 0001104659-26-049442 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-27 | 2026-06-11 | DEF 14A | 0001104659-26-049437 | View SEC Doc Filr Page |
| 8-K | 2026-04-27 | 2026-04-24 | FORM 8-K | 0001104659-26-048997 | View SEC Doc Filr Page |
| 8-K | 2026-04-02 | 2026-04-02 | FORM 8-K | 0001104659-26-039180 | View SEC Doc Filr Page |
| 10-K | 2026-03-25 | 2025-12-31 | 10-K | 0001104659-26-034532 | View SEC Doc Filr Page |
| 8-K | 2026-03-25 | 2026-03-25 | 8-K | 0001104659-26-034523 | View SEC Doc Filr Page |
| 8-K | 2026-03-19 | 2026-03-19 | FORM 8-K | 0001104659-26-031715 | View SEC Doc Filr Page |